Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood. [electronic resource]
Producer: 20040521Description: 157-67 p. digitalISSN:- 0957-5235
- 3',5'-Cyclic-AMP Phosphodiesterases -- antagonists & inhibitors
- Adenosine Diphosphate -- pharmacology
- Arachidonic Acid -- pharmacology
- Aspirin -- pharmacology
- Carbazoles -- pharmacology
- Cilostazol
- Collagen -- pharmacology
- Cyclic Nucleotide Phosphodiesterases, Type 3
- Cyclooxygenase Inhibitors -- pharmacology
- Humans
- Microscopy, Confocal
- Phosphodiesterase Inhibitors -- pharmacology
- Plasma
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- pharmacology
- Receptors, Thromboxane A2, Prostaglandin H2 -- antagonists & inhibitors
- Reproducibility of Results
- Sulfonamides -- pharmacology
- Tetrazoles -- pharmacology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.